Using real-world data from a large health system, researchers compared mortality rates among patients prescribed cenobamate vs those taking other antiseizure medications.
A session at the AHA Scientific Sessions 2025 focused on dilemmas related to antithrombotic therapy following catheter ablation in patients with AF.